These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15516981)

  • 1. Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor.
    Bernard-Pierrot I; Ricol D; Cassidy A; Graham A; Elvin P; Caillault A; Lair S; Broët P; Thiery JP; Radvanyi F
    Oncogene; 2004 Dec; 23(57):9201-11. PubMed ID: 15516981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
    De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
    Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer.
    Ricol D; Cappellen D; El Marjou A; Gil-Diez-de-Medina S; Girault JM; Yoshida T; Ferry G; Tucker G; Poupon MF; Chopin D; Thiery JP; Radvanyi F
    Oncogene; 1999 Dec; 18(51):7234-43. PubMed ID: 10602477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
    Tomlinson DC; L'Hôte CG; Kennedy W; Pitt E; Knowles MA
    Cancer Res; 2005 Nov; 65(22):10441-9. PubMed ID: 16288035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.
    Kim HJ; Kim TY
    Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C; Lasfer M; Groyer A
    Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fibroblast growth factor 10 and its receptor, fibroblast growth factor receptor 2B, in the bovine corpus luteum.
    Castilho AC; Giometti IC; Berisha B; Schams D; Price CA; Amorim RL; Papa PC; Buratini J
    Mol Reprod Dev; 2008 May; 75(5):940-5. PubMed ID: 18163381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
    Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
    Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural kinase-deficient variant of fibroblast growth factor receptor 1.
    Wang LY; Edenson SP; Yu YL; Senderowicz L; Turck CW
    Biochemistry; 1996 Aug; 35(31):10134-42. PubMed ID: 8756477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells.
    Liu Z; Ishiwata T; Zhou S; Maier S; Henne-Bruns D; Korc M; Bachem M; Kornmann M
    Pancreas; 2007 Aug; 35(2):147-57. PubMed ID: 17632321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.